You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 155 No. 18, 9 OCTOBER 1995 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigations
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (50)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Neutropenia and Bacterial Infection in Acquired Immunodeficiency Syndrome

Richard D. Moore, MD; Jeanne C. Keruly; Richard E. Chaisson, MD

Arch Intern Med. 1995;155(18):1965-1970.


Abstract



Background
In human immunodeficiency virus (HIV) disease, neutropenia occurs most commonly in patients who are also severely immunosuppressed. It is not currently known whether neutropenia is an independent risk factor for the development of bacterial infection, which is a potentially serious complication of advanced HIV disease.

Methods
We compared the incidence of bacterial infection between 118 neutropenic patients (absolute neutrophil count [ANC], <1x109/L) and 118 nonneutropenic patients matched for CD4+ lymphocyte count, use of injecting drugs, and follow-up time from a demographically heterogeneous urban cohort of HIV-infected patients followed up longitudinally at the Johns Hopkins Hospital. The incidence of serious infection was analyzed separately for patients with an ANC of less than 1, less than 0.75, or less than 0.5x109/L.

Results
There were no statistically significant associations found between neutropenia and several individual bacterial infections, including bacteremia, pneumonia, endocarditis, bacterial enterocolitis, and infection of normally sterile sites for any level of neutropenia. However, for all these infections combined, the adjusted relative risk for the occurrence of bacterial infection was 2.33 (95% confidence interval, 1.00 to 5.40; P=.05) for patients with an ANC of less than 1x109/L and 7.92 (95% confidence interval, 1.18 to 53.2; P=.03) for those with an ANC of less than 0.5x109/L. The incidence of serious bacterial infection ranged from two to three infections per 100 person-months of neutropenia for patients with an ANC of less than 1x109/L and three to five infections per 100 person-months of neutropenia for patients with an ANC of less than 0.5x109/L for all bacterial infections combined.

Conclusions
Our matched cohort analysis indicates that neutropenia is an independent risk factor for bacterial infection in patients with advanced HIV disease. Given the incidence of infection, the cost-effectiveness of interventions to prevent neutropenia in advanced HIV disease should be assessed.

(Arch Intern Med. 1995;155:1965-1970)



Author Affiliations



From The Johns Hopkins University School of Medicine, Baltimore, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neutropenia in Human Immunodeficiency Virus Infection: Data From the Women's Interagency HIV Study.
Levine et al.
Arch Intern Med 2006;166:405-410.
ABSTRACT | FULL TEXT  

Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients
Mayaud et al.
Eur Respir J 2002;20:28S-39s.
ABSTRACT | FULL TEXT  

Therapeutic Use of Cytokines to Modulate Phagocyte Function for the Treatment of Infectious Diseases: Current Status of Granulocyte Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Interferon-{gamma}
Hubel et al.
The Journal of Infectious Disease 2002;185:1490-1501.
ABSTRACT | FULL TEXT  

Use of Cytokines in Human Immunodeficiency Virus-Infected Patients: Colony-Stimulating Factors, Erythropoietin, and Interleukin-2
Mayer et al.
Clinical Infectious Diseases 2001;32:766-773.
ABSTRACT | FULL TEXT  

Soluble CD16 Inhibits CR3 (CD11b/CD18)-Mediated Infection of Monocytes/Macrophages by Opsonized Primary R5 HIV-1
Bouhlal et al.
J. Immunol. 2001;166:3377-3383.
ABSTRACT | FULL TEXT  

Etiology and Natural History of Neutropenia in Human Immunodeficiency Virus Disease: A Prospective Study
Moore et al.
Clinical Infectious Diseases 2001;32:469-475.
ABSTRACT | FULL TEXT  

Neutropenia, Neutrophil Dysfunction, and Bacterial Infection in Patients with Human Immunodeficiency Virus Disease: The Role of Granulocyte Colony-Stimulating Factor
Kuritzkes
Clinical Infectious Diseases 2000;30:256-270.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus Disease-Related Neutropenia and the Risk of Hospitalization for Bacterial Infection
Jacobson et al.
Arch Intern Med 1997;157:1825-1831.
ABSTRACT  

Neutropenia and latrogenic Neutrophil Dysfunction in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
Arnott et al.
Arch Intern Med 1996;156:1475-1476.
ABSTRACT  

Neutropenia Independently Linked to Bacterial Infection
AIDS Clin Care 1995;1995:7-7.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.